Cargando…
PROTACs in gastrointestinal cancers
Proteolysis targeting chimera (PROTAC) presents a powerful strategy for targeted protein degradation (TPD). The heterobifunctional PROTAC molecule consists of an E3 ligase ligand covalently linked to a protein of interest (POI) via a linker. PROTAC can induce ubiquitinated proteasomal degradation of...
Autores principales: | Chen, Yu, Yang, Qingfan, Xu, Jinrun, Tang, Liyao, Zhang, Yan, Du, Fukuan, Zhao, Yueshui, Wu, Xu, Li, Mingxing, Shen, Jing, Ding, Ruilin, Cao, Hongying, Li, Wanping, Li, Xiaobing, Chen, Meijuan, Wu, Zhigui, Cho, Chi Hin, Du, Yu, Wen, Qinglian, Xiao, Zhangang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676279/ https://www.ncbi.nlm.nih.gov/pubmed/36420306 http://dx.doi.org/10.1016/j.omto.2022.10.012 |
Ejemplares similares
-
Carboranes as unique pharmacophores in antitumor medicinal chemistry
por: Chen, Yu, et al.
Publicado: (2022) -
Synthesis of Oleanolic Acid-Dithiocarbamate Conjugates and Evaluation of Their Broad-Spectrum Antitumor Activities
por: Tang, Liyao, et al.
Publicado: (2023) -
Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022) -
VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment
por: Zhao, Yueshui, et al.
Publicado: (2022) -
Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis
por: Yuan, Donghong, et al.
Publicado: (2021)